top of page
Search

Blood tests for Alzheimer’s disease

The impact of disease prevalence on test performance


Dr. DeMarco (University of British Columbia), Dr. Algeciras-Schimnich (Mayo Clinic) and Dr. Budelier (Tricore Labs) discuss often overlooked, but critically important, considerations in the implementation of blood-based biomarkers for Alzheimer's disease in the journal of Alzheimer's and Dementia.


Blood tests for Alzheimer’s disease: the impact of disease prevalence on test performance


Available online ahead of print: https://doi.org/10.1002/alz.13762


Address
 

St. Paul's Hospital

Dept of Pathology & Laboratory Medicine

1081 Burrard St, Vancouver Canada, V6Z 1Y6

Connect

Web: www.DeMarcoLab.ca

Email: mari.demarco [at] ubc.ca

canada-flag-bw.jpg

© 2020 M.L.DeMarco

bottom of page